Rchr
J-GLOBAL ID:200901045616709307
Update date: May. 02, 2024
Hashimoto Tadafumi
ハシモト タダフミ | Hashimoto Tadafumi
Affiliation and department:
Job title:
director
Research field (1):
Pathobiochemistry
Research keywords (9):
FUS
, TDP-43
, frontotemporal lobar degeneration
, amyotrophic lateral sclerosis
, apolipoprotein E
, CLAC
, senile plaque
, β-アミロイド
, Alzheimer disease
Research theme for competitive and other funds (14):
- 2021 - 2024 Study for the mechanisms of oligomerization and toxicity of FUS
- 2020 - 2023 神経変性疾患におけるストレス依存的な凝集タンパク質の生成・放出機構
- 2020 - 2023 小胞輸送障害の定量的・網羅的解析法の確立によるアルツハイマー病治療薬の探索
- 2018 - 2021 オートファジー機構を介したTDP-43の生理機能及び毒性発揮機序の解明
- 2017 - 2020 Elucidation of the molecular mechanisms of Abeta economy in the brain of Alzheimer's disease
- 2017 - 2020 Lipid flippase is the novel therapeutic target for the Alzheimer disease, which correlate with endocytic traffic impairment.
- 2017 - 2019 ALS病因タンパク質FUSの細胞間伝播及び神経細胞障害性発揮メカニズムの解明
- 2015 - 2017 Elucidation of the pathomechanism of neurodegeneration induced by TDP-43
- 2010 - 2015 Elucidation of the molecular pathology of Alzheimer's disease focusing on the synapses toward therapies
- 2012 - 2013 Study for the metabolism and neurotoxicity of amyloid beta peptide oligomers
- 2007 - 2008 アルツハイマー病脳におけるアミロイド構成蛋白質CLACに関する研究
- 2005 - 2007 Molecular and cell biological studies on the production, aggregation and clearance of Alzheimer amyloid β peptides.
- 2005 - 2006 アルツハイマー病新規アミロイド構成蛋白質CLACに関する病態生化学的研究
- 2003 - 2004 アルツハイマー病脳老人斑アミロイドを構成する新規タンパク質CLACに関する研究
Show all
Papers (72):
-
Rei Murakami, Hirotaka Watanabe, Hideko Hashimoto, Mayu Kashiwagi-Hakozaki, Tadafumi Hashimoto, Celeste M Karch, Takeshi Iwatsubo, Hideyuki Okano. Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau propagation using human pluripotent stem cell-derived models. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2024
-
間野 達雄, 大友 岳, 橋本 唯史, 戸田 達史, 岩田 淳. Hif1aとα-Syn分解 パーキンソン病における神経細胞特異的エピゲノム(Hif1a and α-Syn Degradation: A Neuron-Specific Epigenome in Parkinson's Disease). Dementia Japan. 2023. 37. 4. 708-708
-
Hirotaka Watanabe, Rei Murakami, Kazuya Tsumagari, Satoru Morimoto, Tadafumi Hashimoto, Kent Imaizumi, Iki Sonn, Kaoru Yamada, Yuko Saito, Shigeo Murayama, et al. Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model. Stem Cell Reports. 2023
-
Yuya Kishino, Koji Matsukawa, Taisei Matsumoto, Ryota Miyazaki, Tomoko Wakabayashi, Takashi Nonaka, Fuyuki Kametani, Masato Hasegawa, Tadafumi Hashimoto, Takeshi Iwatsubo. Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration. Journal of Biological Chemistry. 2022. 298. 8. 102191-102191
-
Nanaka Kaneshiro, Masato Komai, Ryosuke Imaoka, Atsuya Ikeda, Yuji Kamikubo, Takashi Saito, Takaomi C Saido, Taisuke Tomita, Tadafumi Hashimoto, Takeshi Iwatsubo, et al. Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer's disease. iScience. 2022. 25. 3. 103869-103869
more...
MISC (29):
-
内上 寛一, 箱崎 眞結, 松原 知康, 村山 繁雄, 齊藤 祐子, 戸田 達史, 橋本 唯史, 岩坪 威. βアミロイド蓄積を誘発する可溶性高分子量AβオリゴマーはAD脳血管に豊富に存在する. 老年精神医学雑誌. 2022. 33. 増刊II. 226-226
-
内上 寛一, 箱崎 眞結, 松原 知康, 村山 繁雄, 齊藤 祐子, 戸田 達史, 橋本 唯史, 岩坪 威. βアミロイド蓄積を誘発する可溶性高分子量AβオリゴマーはAD脳血管に豊富に存在する. Dementia Japan. 2022. 36. 4. 744-744
-
岸野祐也, 岸野祐也, 岸野祐也, 松川浩二, 松本大成, 宮崎良太, 宮崎良太, 若林朋子, 若林朋子, 野中隆, et al. casein kinase 1δ/εがFUSの神経毒性に与える影響に関する検討. Dementia Japan. 2022. 36. 4
-
内上寛一, 内上寛一, 箱崎眞結, 松原知康, 村山繁雄, 村山繁雄, 齊藤祐子, 戸田達史, 橋本唯史, 橋本唯史, et al. 脳内でβアミロイドーシスを誘発する可溶な高分子量Aβ分子種は,ヒトアルツハイマー病脳においてはCAAの目立つケースで豊富に存在する. 日本神経化学会大会抄録集(Web). 2022. 65th
-
坂内太郎, 間野達雄, 陳西貴, 大友亮, 大友岳, 橋本唯史, 岡澤均, 岩坪威, 岩田淳, 戸田達史. 慢性脳低灌流がアルツハイマー病における脳内アミロイドβ蓄積を増加させる機序の解明. Dementia Japan. 2018. 32. 3. 415-415
more...
Education (2):
- 1998 - 2001 東京大学大学院 薬学系研究科 生命薬学専攻
- 1993 - 1997 The University of Tokyo Faculty of Pharmaceutical Sciences Department of Pharmacy
Professional career (1):
Work history (8):
- 2021/09 - 現在 National Center of Neurology and Psychiatry Department of Degenerative Neurological Diseases Director
- 2017/07 - 2021/08 The University of Tokyo Graduate School of Medicine
- 2016 - 2021/08 The University of Tokyo Graduate School of Medicine
- 2012 - 2016 The University of Tokyo Graduate School of Medicine
- 2011 - 2012 The University of Tokyo Graduate School of Medicine
- 2010 - 2011 Massachusetts General Hospital Alzheimer's disease research unit Instructor
- 2008 - 2010 Massachusetts General Hospital Alzheimer's disease research unit Research fellow
- 2001 - 2008 The University of Tokyo Graduate School of Pharmaceutical Sciences
Show all
Committee career (1):
Association Membership(s) (6):
日本神経病理学会
, 日本神経化学会
, 日本神経科学学会
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, JAPAN SOCIETY FOR DEMENTIA RESEARCH
, Society for Neuroscience
Return to Previous Page